Detecting mutations in MMR genes has been mainly carried out in Lynch patients with tumors with high MSI, which may explain the lower frequency of observed mutations in MSH6. Moreover, mutations in MSH6 confer a relatively greater risk of endometrial cancer [19,20]. Here, MSH6 is linked to endometrial cancer.